Health Dialog Services Corp:企業の戦略的SWOT分析

◆英語タイトル:Health Dialog Services Corp - Strategic SWOT Analysis Review
◆商品コード:DATA904C0276
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Health Dialog Services Corp – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Health Dialog Services Corp (Health Dialog), a subsidiary of Rite Aid Corp is a provider of healthcare analytics and decision support services. The company’s service portfolio encompass coaching for medical decisions, chronic conditions and wellness services, population analytic solutions, and consulting services. It also offers a range of programs including chronic condition programs, wellness programs, population insight, member engagement and shared savings programs, and shared decision making tools. Health Dialog serves physician groups, health plans, government agencies, self-insured employers, provider groups and government healthcare programs. The company has offices and coaching centers in Bedford, Portland, San Antonio and Scottsdale, the US. Health Dialog is headquartered in Boston, Massachusetts, the US.

Health Dialog Services Corp Key Recent Developments

Jun 19,2018: Health Dialog Joins Clinical, Business and Government Leaders to Discuss Best Practices for Patient Engagement Success
Dec 12,2017: Health Dialog Achieves 15 Consecutive Years of NCQA Accreditation for Disease Management Programs
Jul 24,2017: Health Dialog Introduces New Medication Therapy Management Services

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Health Dialog Services Corp – Key Facts 5
Health Dialog Services Corp – Key Employees 6
Health Dialog Services Corp – Key Employee Biographies 7
Health Dialog Services Corp – Major Products and Services 8
Health Dialog Services Corp – History 9
Health Dialog Services Corp – Company Statement 11
Health Dialog Services Corp – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Health Dialog Services Corp – Business Description 14
Health Dialog Services Corp – Corporate Strategy 15
Health Dialog Services Corp – SWOT Analysis 16
SWOT Analysis – Overview 16
Health Dialog Services Corp – Strengths 16
Health Dialog Services Corp – Weaknesses 17
Health Dialog Services Corp – Opportunities 18
Health Dialog Services Corp – Threats 19
Health Dialog Services Corp – Key Competitors 20
Section 3 – Company’s Lifesciences Financial Deals and Alliances 21
Health Dialog Services Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
Health Dialog Services Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22
Health Dialog Services Corp, Recent Deals Summary 23
Section 4 – Company’s Recent Developments 24
Jun 19, 2018: Health Dialog Joins Clinical, Business and Government Leaders to Discuss Best Practices for Patient Engagement Success 24
Dec 12, 2017: Health Dialog Achieves 15 Consecutive Years of NCQA Accreditation for Disease Management Programs 25
Jul 24, 2017: Health Dialog Introduces New Medication Therapy Management Services 26
Section 5 – Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Health Dialog Services Corp, Key Facts 5
Health Dialog Services Corp, Key Employees 6
Health Dialog Services Corp, Key Employee Biographies 7
Health Dialog Services Corp, Major Products and Services 8
Health Dialog Services Corp, History 9
Health Dialog Services Corp, Other Locations 12
Health Dialog Services Corp, Key Competitors 20
Health Dialog Services Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
Health Dialog Services Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22
Health Dialog Services Corp, Recent Deals Summary 23

List of Figures
Health Dialog Services Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
Health Dialog Services Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 22

★海外企業調査レポート[Health Dialog Services Corp:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Flotek Industries Inc (FTK):企業の財務・戦略的SWOT分析
    Summary Flotek Industries Inc (Flotek) is a developer of chemistry based technology solutions for energy, industrial and consumer applications. The company offers stimulation chemistry, cementing chemistry, improved oil recovery chemistry, drilling fluid additives, and coil tubing chemistry. Its sti …
  • Africa Oil Corp (AOI):石油・ガス:M&Aディール及び事業提携情報
    Summary Africa Oil Corp (AOC) is an oil and gas company that discovers, develops, explores and produces oil and gas assets. The company has oil discoveries in Ekales, Agete, Amosing, Ewoi wells in the Lokichar Basin, and others. It owns and operates various blocks including block 9, block 10A, block …
  • PNE Wind AG (PNE3):企業の財務・戦略的SWOT分析
    PNE Wind AG (PNE3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Dollarama Inc:戦略・SWOT・企業財務分析
    Dollarama Inc - Strategy, SWOT and Corporate Finance Report Summary Dollarama Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • China CITIC Bank Corporation Limited:企業の戦略・SWOT・財務情報
    China CITIC Bank Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China CITIC Bank Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Zain Group (ZAIN):企業の財務・戦略的SWOT分析
    Zain Group (ZAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • VentiRx Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary VentiRx Pharmaceuticals Inc (VentiRx) is a biopharmaceutical company that develops and commercializes drugs for the treatment of respiratory, autoimmune diseases and cancer. The company develops toll like receptor 8 agonist and antagonists for the treatment of cancer, respiratory and autoimm …
  • In-N-Out Burgers:企業の戦略・SWOT・財務情報
    In-N-Out Burgers - Strategy, SWOT and Corporate Finance Report Summary In-N-Out Burgers - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cydan Development Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cydan Development Inc (Cydan) is an orphan drug accelerator dedicated to advancing therapies for rare genetic diseases. The company identifies assets with biology and proof-of-concept data in vivo models from academic circles, industry, and other sources. It offers various technology platfor …
  • Piramal Enterprises Ltd (PEL):医療機器:M&Aディール及び事業提携情報
    Summary Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. I …
  • F J Benjamin Holdings Ltd.:企業の戦略・SWOT・財務情報
    F J Benjamin Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary F J Benjamin Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Repros Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The company’s pipeline product includes enclomiphene and proellex. Its enclomiphene is an …
  • Toda Corporation:企業の戦略・SWOT・財務分析
    Toda Corporation - Strategy, SWOT and Corporate Finance Report Summary Toda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • A&D Company Ltd (7745):企業の財務・戦略的SWOT分析
    Summary A&D Company Ltd (A&D Company) is a medical equipment company that manufactures, designs, develops, and distributes advanced measuring, controlling, monitoring, and testing instruments. The company’s products include powertrain testing systems, digital analog converter, DSP platform, model ba …
  • Protagonist Therapeutics Inc (PTGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protagonist Therapeutics Inc (Protagonist) is a clinical-stage biopharmaceutical company that discovers and develops orally stable peptides as targeted therapies. The company through its proprietary technology platform develops structurally novel oral or injectable peptides for protein-prote …
  • ASGN Inc (ASGN):企業の財務・戦略的SWOT分析
    Summary ASGN Inc (ASGN), formerly known as On Assignment Inc, provides professionals for technology, life sciences, and creative sectors. It offers qualified professionals and human capital services. The company’s cybercoders recruits professionals for engineering, technology, sales, executive, fina …
  • Blueberry Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a healthcare products provider that develops therapeutic products. The company develops novel therapies to treat onychomycosis. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea ped …
  • Vodafone Group Plc (VOD):企業の財務・戦略的SWOT分析
    Vodafone Group Plc (VOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Atlantic Power Corporation (ATP)-エネルギー分野:企業M&A・提携分析
    Summary Atlantic Power Corporation (Atlantic Power) is an electric utility that owns and operates diversified power generation assets. It produces electricity from various sources including biomass, coal, hydro, and natural gas sources. The company sells power to utilities and other large commercial …
  • ImmunoGen Inc (IMGN):医療機器:M&Aディール及び事業提携情報
    Summary ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of antibody-drug conjugate therapies for the treatment of cancer. The company’s lead product candidate, mirvetuximab soravtansine, a folate receptor alpha (FRa) intended for the treatment of p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆